NeoFuse
Phase 1/2Completed 0 watching 0 views this week๐ค Quiet
36
Development Stage
โ
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Cervical Degenerative Disc Disease
Conditions
Cervical Degenerative Disc Disease, Degenerative Spondylolisthesis, Spinal Stenosis
Trial Timeline
Jun 1, 2010 โ Mar 1, 2013
NCT ID
NCT01106417About NeoFuse
NeoFuse is a phase 1/2 stage product being developed by Mesoblast for Cervical Degenerative Disc Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT01106417. Target conditions include Cervical Degenerative Disc Disease, Degenerative Spondylolisthesis, Spinal Stenosis.
Hype Score Breakdown
Clinical
13
Activity
8
Company
5
Novelty
4
Community
3
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01097486 | Phase 2 | Completed |
| NCT01106417 | Phase 1/2 | Completed |
| NCT00549913 | Phase 1/2 | Completed |
Competing Products
20 competing products in Cervical Degenerative Disc Disease